Skip to content

Effects of Lagenbone on Bone Mineral Density

Effects of Lagenbone on Improvements in Bone Mineral Density - A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04557553
Enrollment
10
Registered
2020-09-21
Start date
2019-07-15
Completion date
2022-07-13
Last updated
2023-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

chinese medicine, herbal medicine, osteoporosis, bone mineral density

Brief summary

To study the effects of the herbal supplement Lagenbone on Bone Mineral Density

Detailed description

To study the effects of the herbal supplement Lagenbone on Bone Mineral Density. Lagenbone is a supplement based on the Chinese Herbal formula Gui Lu Er Xian Jiao.

Interventions

DIETARY_SUPPLEMENTLagenbone

Traditional Chinese medicine herbal formula

Sponsors

Sun Ten Pharmaceutical Co., Ltd.
CollaboratorINDUSTRY
Southern California University of Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of osteoporosis * Able to read and understand English * Willing to receive routine DEXA scans and comply with supplement schedule

Exclusion criteria

* Pregnant, lactating, or having gestational diabetes * Diagnosed with comorbid conditions that they are taking medication for e.g. Acid reflux, Hashimoto's/Grave's Disease, Endometriosis, prostate, breast, uterine cancer, kidney disease, fibroids, psychological disorders * Use of any medication known to interfere with bone mineral density * Are taking any new medications/supplements/treatments/therapeutic exercise within the last two months for osteoporosis or bone density * Involved in health-related litigation, claims * Missing baseline visits * Vegan or vegetarian * Diagnosed with Alzheimer's or demonstrating onset of dementia

Design outcomes

Primary

MeasureTime frameDescription
Dual-energy x-ray absorptiometry (DXA)DEXA Scan15 monthsDual-energy x-ray absorptiometry (DXA) or bone densitometry or Bone Density Scan

Secondary

MeasureTime frameDescription
Short Osteoporosis Quality of Life Questionnaire (ECOS16)15 monthsShort Osteoporosis Quality of Life Questionnaire
36-item Short form survey (SF36)15 months36-item Short form survey
Osteoporotic Quality of Life Questionnaire (OQLQ10)15 monthsOsteoporotic Quality of Life Questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026